Ad is loading...
EMEAX
Price
$11.36
Change
-$0.07 (-0.61%)
Updated
Nov 15 closing price
RNWFX
Price
$80.56
Change
-$0.79 (-0.97%)
Updated
Nov 15 closing price
Ad is loading...

EMEAX vs RNWFX

Header iconEMEAX vs RNWFX Comparison
Open Charts EMEAX vs RNWFXBanner chart's image
Ashmore Emerging Markets Equity A
Price$11.36
Change-$0.07 (-0.61%)
VolumeN/A
CapitalizationN/A
American Funds New World R5
Price$80.56
Change-$0.79 (-0.97%)
VolumeN/A
CapitalizationN/A
EMEAX vs RNWFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
EMEAX vs. RNWFX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EMEAX is a StrongSell and RNWFX is a Buy.

FUNDAMENTALS
Fundamentals
RNWFX has more cash in the bank: 60.9B vs. EMEAX (159M). RNWFX pays higher dividends than EMEAX: RNWFX (1.51) vs EMEAX (0.83). EMEAX was incepted earlier than RNWFX: EMEAX (13 years) vs RNWFX (23 years). EMEAX is a more actively managed with annual turnover of: 79.00 vs. RNWFX (32.00). RNWFX has a lower initial minimum investment than EMEAX: RNWFX (250) vs EMEAX (1000). EMEAX annual gain was more profitable for investors over the last year : 12.28 vs. RNWFX (11.54). RNWFX return over 5 years is better than : 17.17 vs. EMEAX (3.98).
EMEAXRNWFXEMEAX / RNWFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence13 years23 years-
Gain YTD8.4187.099119%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets159M60.9B0%
Annual Yield % from dividends0.831.5155%
Returns for 1 year12.2811.54106%
Returns for 3 years-31.78-14.55218%
Returns for 5 years3.9817.1723%
Returns for 10 years40.1341.0098%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VRNA35.660.29
+0.82%
Verona Pharma plc
BURL268.94-0.65
-0.24%
Burlington Stores
RCMT22.25-0.38
-1.68%
RCM Technologies
SNTI2.15-0.18
-7.73%
Senti Biosciences Inc.
CATX7.88-1.04
-11.66%
Perspective Therapeutics